You missed the point of dfrai’s post. dfrai was not putting a valuation multiple on MNTA’s Lovenox sales, but rather was trying to estimate the sales level MNTA expects based on MNTA’s guidance for the time required to repay the amount owed to NVS.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”